Algorithms and heuristics of health technology assessments
A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries
Datos Bibliográficos
| ID | 4944281 |
|---|---|
| Autores | Panos Kanavos (0000-0001-9518-3089, London School of Economics and Political Science, autor de correspondencia), Erica Visintin (London School of Economics and Political Science), Arianna Gentilini (0000-0002-6943-6158, London School of Economics and Political Science) |
| Año | 2023 |
| Volumen | 331 |
| Páginas | 116045 |
| Fecha de publicación | 2023-08-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Social Science & Medicine (JOURNAL) |
| Identificadores de la revista | ISSN: 0277-9536 • E-ISSN: 1873-5347 |
| Editorial | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.socscimed.2023.116045 |
| PMID | 37450991 |
| OpenAlex | W4382051784 |
| Idioma | EN |
| Citas recibidas | 2 |
| Referencias citadas | 41 |
Actuarial science · Economic growth · Economics · Equity (law · Health care · Health technology · Orphan drug · Political science · Propensity score matching · Public economics · Health Systems, Economic Evaluations, Quality of Life · Healthcare cost, quality, practices · Medicine · Pharmaceutical Economics and Policy · Internal Medicine
RoB 2
On Limiting the Domain of Inequality
Welfarism, extra-welfarism and capability
Dealing with uncertainty and high prices of new medicines
Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond
Innovation as a value in healthcare priority-setting
| Obras citantes distintas | 2 |
|---|---|
| Citas por año | 1 |
| Intervalo de citas | 2024 - 2026 (3) |
| Velocidad de citación | current |
| Altamente citado | No |
| Tipos de cita | Neutras: 2 |